Evaluating the evidence for assessing BNP and NT-proBNP levels.
To provide an overview of 5 systematic reviews in this issue of Clinical Biochemistry addressing the diagnostic and prognostic power of natriuretic peptides. Editorial. Limited quality of the primary studies and the large variability in their results limit the inferences that can be drawn from reviews in this series. The current data justify neither enthusiastic use, nor confident rejection, of BNP and NT-proBNP levels to inform the prognosis or diagnosis of heart failure.